Optimization of the Cardiovascular Therapeutic Properties of Mesenchymal Stromal/Stem Cells-Taking the Next Step

Stem Cell Reviews and Reports

Volumn 9, Issue 3, 2013, Pages 281-302

  Richardson, James D ^a   Nelson, Adam J ^a   Zannettino, Andrew C W ^b   Gronthos, Stan ^b   Worthley, Stephen G ^a   Psaltis, Peter J ^a,c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c MAYO CLINIC   (United States)

Author keywords

Cardiomyopathy; Ischemic heart disease; Limitations; Mesenchymal precursor cells; Mesenchymal stem cells; Myocardial infarction; Optimization; Paracrine; Pre conditioning; Tissue engineering

Indexed keywords

ANGIOGENESIS; ARTICLE; BIOLOGICAL THERAPY; CARDIOMYOPATHY; CULTURE TECHNIQUE; CYTOLOGY; GENETIC ENGINEERING; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; REGENERATION;

CARDIOMYOPATHIES; CELL CULTURE TECHNIQUES; CELL- AND TISSUE-BASED THERAPY; GENETIC ENGINEERING; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; REGENERATION;

EID: 84878965378     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-012-9366-7     Document Type: Article

References (188)

1. Ho, K., Anderson, K., Kannel, W., Grossman, W., & Levy, D. (1993). Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation, 88, 107-115.
2. Fuchs, S., Baffour, R., Zhou, Y. F., et al. (2001). Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. Journal of the American College of Cardiology, 37, 1726-1732.
3. Lunde, K., Solheim, S., Aakhus, S., et al. (2006). Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. The New England Journal of Medicine, 355, 1199-1209.
4. Orlic, D., Kajstura, J., Chimenti, S., et al. (2001). Bone marrow cells regenerate infarcted myocardium. Nature, 410, 701-705.
5. Losordo, D. W., Henry, T. D., Davidson, C., et al. (2011). Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circulation Research, 109, 428-436.
6. Menasche, P., Hagege, A. A., Vilquin, J. T., et al. (2003). Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. Journal of the American College of Cardiology, 41, 1078-1083.
7. Psaltis, P. J., Zannettino, A. C. W., Worthley, S. G., & Gronthos, S. (2008). Concise review: Mesenchymal stromal cells: Potential for cardiovascular repair. Stem Cells, 26, 2201-2210.
8. Psaltis, P. J., Harbuzariu, A., Delacroix, S., Holroyd, E. W., & Simari, R. D. (2011). Resident vascular progenitor cells-diverse origins, phenotype, and function. Journal of Cardiovascular Translational Research, 4, 161-176.
9. Sabatini, F., Petecchia, L., Tavian, M., Jodon de Villeroche, V., Rossi, G. A., & Brouty-Boye, D. (2005). Human bronchial fibroblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities. Laboratory Investigation, 85, 962-971.
10. Zannettino, A. C. W., Paton, S., Arthur, A., et al. (2008). Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. Journal of Cellular Physiology, 214, 413-421.
11. Shi, S., & Gronthos, S. (2003). Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. Journal of Bone and Mineral Research, 18, 696-704.
12. Roufosse, C. A., Direkze, N. C., Otto, W. R., & Wright, N. A. (2004). Circulating mesenchymal stem cells. The International Journal of Biochemistry & Cell Biology, 36, 585-597.
13. Lee, O. K., Kuo, T. K., Chen, W. M., Lee, K. D., Hsieh, S. L., & Chen, T. H. (2004). Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood, 103, 1669-1675.
14. In't Anker, P. S., Scherjon, S. A., Kleijburg-van der Keur, C., et al. (2004). Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells, 22, 1338-1345.
15. Chen, S. L., Fang, W. W., Ye, F., et al. (2004). Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. The American Journal of Cardiology, 94, 92-95.
16. Amado, L. C., Saliaris, A. P., Schuleri, K. H., et al. (2005). Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proceedings of the National Academy of Sciences of the United States of America, 102, 11474-11479.
17. Hare, J. M., Traverse, J. H., Henry, T. D., et al. (2009). A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. Journal of the American College of Cardiology, 54, 2277-2286.
18. Quevedo, H. C., Hatzistergos, K. E., Oskouei, B. N., et al. (2009). Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proceedings of the National Academy of Sciences of the United States of America, 106, 14022-14027.
19. Psaltis, P. J., Carbone, A., Nelson, A. J., et al. (2010). Reparative effects of allogeneic mesenchymal precursor cells delivered transendocardially in experimental nonischemic cardiomyopathy. JACC. Cardiovascular Interventions, 3, 974-983.
20. Knight, R. L., Booth, C., Wilcox, H. E., Fisher, J., & Ingham, E. (2005). Tissue engineering of cardiac valves: Re-seeding of acellular porcine aortic valve matrices with human mesenchymal progenitor cells. The Journal of Heart Valve Disease, 14, 806-813.
21. Yokokawa, M., Ohnishi, S., Ishibashi-Ueda, H., et al. (2008). Transplantation of mesenchymal stem cells improves atrioventricular conduction in a rat model of complete atrioventricular block. Cell Transplantation, 17, 1145-1155.
22. Vulliet, P. R., Greeley, M., Halloran, S. M., MacDonald, K. A., & Kittleson, M. D. (2004). Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet, 363, 783-784.
23. Friedenstein, A. J., Chailakhjan, R. K., & Lalykina, K. S. (1970). The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell and Tissue Kinetics, 3, 393-403.
24. Psaltis, P. J., Paton, S., See, F., et al. (2010). Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations. Journal of Cellular Physiology, 223, 530-540.
25. Dominici, M., Le Blanc, K., Mueller, I., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8, 315-317.
26. Toma, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J., & Kessler, P. D. (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation, 105, 93-98.
27. Gnecchi, M., He, H., Melo, L. G., et al. (2009). Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Stem Cells, 27, 971-979.
28. Mills, W. R., Mal, N., Kiedrowski, M. J., et al. (2007). Stem cell therapy enhances electrical viability in myocardial infarction. Journal of Molecular and Cellular Cardiology, 42, 304-314.
29. Ohnishi, S., Yanagawa, B., Tanaka, K., et al. (2007). Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis. Journal of Molecular and Cellular Cardiology, 42, 88-97.
30. Nagaya, N., Kangawa, K., Itoh, T., et al. (2005). Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation, 112, 1128-1135.
31. van Linthout, S., Savvatis, K., Miteva, K., et al. (2011). Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis. European Heart Journal, 32(17), 2168-2178.
32. Freyman, T., Polin, G., Osman, H., et al. (2006). A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. European Heart Journal, 27, 1114-1122.
33. Hatzistergos, K. E., Quevedo, H., Oskouei, B. N., et al. (2010). Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circulation Research, 107, 913-922.
34. Kraitchman, D. L., Heldman, A. W., Atalar, E., et al. (2003). In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation, 107, 2290-2293.
35. Gyongyosi, M., Blanco, J., Marian, T., et al. (2008). Serial noninvasive in vivo positron emission tomographic tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression. Circulation. Cardiovascular Imaging, 1, 94-103.
36. Perin, E. C., Tian, M., Marini, F. C., 3rd, et al. (2011). Imaging long-term fate of intramyocardially implanted mesenchymal stem cells in a porcine myocardial infarction model. PLoS One, 6, e22949.
37. Psaltis, P. J., Simari, R. D., & Rodriguez-Porcel, M. (2012). Emerging roles for integrated imaging modalities in cardiovascular cell-based therapeutics: A clinical perspective. European Journal of Nuclear Medicine and Molecular Imaging, 39, 165-181.
38. Silva, G. V., Litovsky, S., Assad, J. A., et al. (2005). Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation, 111, 150-156.
39. Schuleri, K. H., Amado, L. C., Boyle, A. J., et al. (2008). Early improvement in cardiac tissue perfusion due to mesenchymal stem cells. American Journal of Physiology - Heart and Circulatory Physiology, 294, H2002-H2011.
40. Arminan, A., Gandia, C., Bartual, M., et al. (2009). Cardiac differentiation is driven by NKX2. 5 and GATA4 nuclear translocation in tissue-specific mesenchymal stem cells. Stem Cells and Development, 18, 907-918.
41. Gao, L. R., Zhang, N. K., Bai, J., et al. (2010). The apelin-APJ pathway exists in cardiomyogenic cells derived from mesenchymal stem cells in vitro and in vivo. Cell Transplantation, 19, 949-958.
42. Ge, D., Liu, X., Li, L., et al. (2009). Chemical and physical stimuli induce cardiomyocyte differentiation from stem cells. Biochemical and Biophysical Research Communications, 381, 317-321.
43. Genovese, J. A., Spadaccio, C., Chachques, E., et al. (2009). Cardiac pre-differentiation of human mesenchymal stem cells by electrostimulation. Frontiers in Bioscience, 14, 2996-3002.
44. Makino, S., Fukuda, K., Miyoshi, S., et al. (1999). Cardiomyocytes can be generated from marrow stromal cells in vitro. The Journal of Clinical Investigation, 103, 697-705.
45. Balana, B., Nicoletti, C., Zahanich, I., et al. (2006). 5-Azacytidine induces changes in electrophysiological properties of human mesenchymal stem cells. Cell Research, 16, 949-960.
46. Feng, C., Zhu, J., Zhao, L., et al. (2009). Suberoylanilide hydroxamic acid promotes cardiomyocyte differentiation of rat mesenchymal stem cells. Experimental Cell Research, 315, 3044-3051.
47. Yoon, J., Min, B. G., Kim, Y. H., Shim, W. J., Ro, Y. M., & Lim, D. S. (2005). Differentiation, engraftment and functional effects of pre-treated mesenchymal stem cells in a rat myocardial infarct model. Acta Cardiologica, 60, 277-284.
48. Forte, G., Minieri, M., Cossa, P., et al. (2006). Hepatocyte growth factor effects on mesenchymal stem cells: Proliferation, migration, and differentiation. Stem Cells, 24, 23-33.
49. Li, H., Yu, B., Zhang, Y., Pan, Z., & Xu, W. (2006). Jagged1 protein enhances the differentiation of mesenchymal stem cells into cardiomyocytes. Biochemical and Biophysical Research Communications, 341, 320-325.
50. Herrmann, J. L., Abarbanell, A. M., Weil, B. R., et al. (2010). Postinfarct intramyocardial injection of mesenchymal stem cells pretreated with TGF-alpha improves acute myocardial function. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, 299, R371-R378.
51. Koninckx, R., Hensen, K., Daniels, A., et al. (2009). Human bone marrow stem cells co-cultured with neonatal rat cardiomyocytes display limited cardiomyogenic plasticity. Cytotherapy, 11, 778-792.
52. He, X. Q., Chen, M. S., Li, S. H., et al. (2010). Co-culture with cardiomyocytes enhanced the myogenic conversion of mesenchymal stromal cells in a dose-dependent manner. Molecular and Cellular Biochemistry, 339, 89-98.
53. Labovsky, V., Hofer, E. L., Feldman, L., et al. (2010). Cardiomyogenic differentiation of human bone marrow mesenchymal cells: Role of cardiac extract from neonatal rat cardiomyocytes. Differentiation, 79, 93-101.
54. Nygren, J. M., Jovinge, S., Breitbach, M., et al. (2004). Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nature Medicine, 10, 494-501.
55. Martens, T. P., See, F., Schuster, M. D., et al. (2006). Mesenchymal lineage precursor cells induce vascular network formation in ischemic myocardium. Nature Clinical Practice. Cardiovascular Medicine, 3(Suppl 1), S18-S22.
56. Shake, J. G., Gruber, P. J., Baumgartner, W. A., et al. (2002). Mesenchymal stem cell implantation in a swine myocardial infarct model: Engraftment and functional effects. The Annals of Thoracic Surgery, 73, 1919-1925.
57. Tsuji, H., Miyoshi, S., Ikegami, Y., et al. (2010). Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes. Circulation Research, 106, 1613-1623.
58. Jumabay, M., Zhang, R., Yao, Y., Goldhaber, J. I., & Bostrom, K. I. (2010). Spontaneously beating cardiomyocytes derived from white mature adipocytes. Cardiovascular Research, 85, 17-27.
59. Gnecchi, M., Zhang, Z., Ni, A., & Dzau, V. J. (2008). Paracrine mechanisms in adult stem cell signaling and therapy. Circulation Research, 103, 1204-1219.
60. Godier-Furnemont, A. F., Martens, T. P., Koeckert, M. S., et al. (2011). Composite scaffold provides a cell delivery platform for cardiovascular repair. Proceedings of the National Academy of Sciences of the United States of America, 108, 7974-7979.
61. Thangarajah, H., Vial, I. N., Chang, E., et al. (2009). IFATS collection: Adipose stromal cells adopt a proangiogenic phenotype under the influence of hypoxia. Stem Cells, 27, 266-274.
62. See, F., Seki, T., Psaltis, P. J., et al. (2010) Therapeutic effects of human STRO-3-selected mesenchymal precursor cells and their soluble factors in experimental myocardial ischemia. Journal of Cellular and Molecular Medicine.
63. Mangi, A. A., Noiseux, N., Kong, D., et al. (2003). Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nature Medicine, 9, 1195-1201.
64. Kinnaird, T., Stabile, E., Burnett, M. S., et al. (2004). Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circulation Research, 94, 678-685.
65. Xu, M., Uemura, R., Dai, Y., Wang, Y., Pasha, Z., & Ashraf, M. (2007). In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function. Journal of Molecular and Cellular Cardiology, 42, 441-448.
66. Rogers, T. B., Pati, S., Gaa, S., et al. (2011). Mesenchymal stem cells stimulate protective genetic reprogramming of injured cardiac ventricular myocytes. Journal of Molecular and Cellular Cardiology, 50, 346-356.
67. Benzhi, C., Limei, Z., Ning, W., et al. (2009). Bone marrow mesenchymal stem cells upregulate transient outward potassium currents in postnatal rat ventricular myocytes. Journal of Molecular and Cellular Cardiology, 47, 41-48.
68. Lai, R. C., Arslan, F., Lee, M. M., et al. (2010). Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Research, 4, 214-222.
69. Du, Y. Y., Zhou, S. H., Zhou, T., et al. (2008). Immuno-inflammatory regulation effect of mesenchymal stem cell transplantation in a rat model of myocardial infarction. Cytotherapy, 10, 469-478.
70. Lee, R. H., Pulin, A. A., Seo, M. J., et al. (2009). Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell, 5, 54-63.
71. Ishikane, S., Yamahara, K., Sada, M., et al. (2010). Allogeneic administration of fetal membrane-derived mesenchymal stem cells attenuates acute myocarditis in rats. Journal of Molecular and Cellular Cardiology, 49, 753-761.
72. Li, L., Zhang, S., Zhang, Y., Yu, B., Xu, Y., & Guan, Z. (2009). Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure. Molecular Biology Reports, 36, 725-731.
73. Dixon, J. A., Gorman, R. C., Stroud, R. E., et al. (2009). Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction. Circulation, 120, S220-S229.
74. Schneider, C., Jaquet, K., Geidel, S., et al. (2009). Transplantation of bone marrow-derived stem cells improves myocardial diastolic function: Strain rate imaging in a model of hibernating myocardium. Journal of the American Society of Echocardiography, 22, 1180-1189.
75. Javazon, E. H., Colter, D. C., Schwarz, E. J., & Prockop, D. J. (2001). Rat marrow stromal cells are more sensitive to plating density and expand more rapidly from single-cell-derived colonies than human marrow stromal cells. Stem Cells, 19, 219-225.
76. Miura, M., Miura, Y., Padilla-Nash, H. M., et al. (2006). Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells, 24, 1095-1103.
77. Jeong, J. O., Han, J. W., Kim, J. M., et al. (2011). Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy. Circulation Research, 108, 1340-1347.
78. Schachinger, V., Erbs, S., Elsasser, A., et al. (2006). Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. The New England Journal of Medicine, 355, 1210-1221.
79. Wollert, K. C., Meyer, G. P., Lotz, J., et al. (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet, 364, 141-148.
80. Lipinski, M. J., Biondi-Zoccai, G. G., Abbate, A., et al. (2007). Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: A collaborative systematic review and meta-analysis of controlled clinical trials. Journal of the American College of Cardiology, 50, 1761-1767.
81. Pfeffer, M. A., Greaves, S. C., Arnold, J. M. O., et al. (1997). Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction: The healing and early afterload reducing therapy trial. Circulation, 95, 2643-2651.
82. Katritsis, D. G., Sotiropoulou, P. A., Karvouni, E., et al. (2005). Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheterization and Cardiovascular Interventions, 65, 321-329.
83. Yang, Z., Zhang, F., Ma, W., et al. (2010). A novel approach to transplanting bone marrow stem cells to repair human myocardial infarction: Delivery via a noninfarct-relative artery. Cardiovascular Therapeutics, 28, 380-385.
84. Chen, S., Liu, Z., Tian, N., et al. (2006). Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery. The Journal of Invasive Cardiology, 18, 552-556.
85. Katritsis, D. G., Sotiropoulou, P., Giazitzoglou, E., Karvouni, E., & Papamichail, M. (2007). Electrophysiological effects of intracoronary transplantation of autologous mesenchymal and endothelial progenitor cells. Europace, 9, 167-171.
86. Williams, A. R., Trachtenberg, B., Velazquez, D. L., et al. (2011). Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: Functional recovery and reverse remodeling. Circulation Research, 108, 792-796.
87. Di Nicola, M., Carlo-Stella, C., Magni, M., et al. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 99, 3838-3843.
88. Fischer, U. M., Harting, M. T., Jimenez, F., et al. (2009). Pulmonary passage is a major obstacle for intravenous stem cell delivery: The pulmonary first-pass effect. Stem Cells and Development, 18, 683-692.
89. Nauta, A. J., Westerhuis, G., Kruisselbrink, A. B., Lurvink, E. G., Willemze, R., & Fibbe, W. E. (2006). Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood, 108, 2114-2120.
90. Poncelet, A. J., Vercruysse, J., Saliez, A., & Gianello, P. (2007). Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo. Transplantation, 83, 783-790.
91. Robey, T. E., Saiget, M. K., Reinecke, H., & Murry, C. E. (2008). Systems approaches to preventing transplanted cell death in cardiac repair. Journal of Molecular and Cellular Cardiology, 45, 567-581.
92. Reinecke, H., Zhang, M., Bartosek, T., & Murry, C. E. (1999). Survival, integration, and differentiation of cardiomyocyte grafts: A study in normal and injured rat hearts. Circulation, 100, 193-202.
93. Simmons, P. J., & Torok-Storb, B. (1991). Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood, 78, 55-62.
94. Gronthos, S., Simmons, P. J., Graves, S. E., & Robey, P. G. (2001). Integrin-mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix. Bone, 28, 174-181.
95. Simmons, P. J., Masinovsky, B., Longenecker, B. M., Berenson, R., Torok-Storb, B., & Gallatin, W. M. (1992). Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood, 80, 388-395.
96. Sacchetti, B., Funari, A., Michienzi, S., et al. (2007). Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell, 131, 324-336.
97. Quirici, N., Soligo, D., Bossolasco, P., Servida, F., Lumini, C., & Deliliers, G. L. (2002). Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Experimental Hematology, 30, 783-791.
98. Gronthos, S., & Simmons, P. J. (1995). The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. Blood, 85, 929-940.
99. Schwab, K. E., & Gargett, C. E. (2007). Co-expression of two perivascular cell markers isolates mesenchymal stem-like cells from human endometrium. Human Reproduction, 22, 2903-2911.
100. Gronthos, S., Fitter, S., Diamond, P., Simmons, P. J., Itescu, S., & Zannettino, A. C. (2007). A novel monoclonal antibody (STRO-3) identifies an isoform of tissue nonspecific alkaline phosphatase expressed by multipotent bone marrow stromal stem cells. Stem Cells and Development, 16, 953-963.
101. Gronthos, S., McCarty, R., Mrozik, K., et al. (2009). Heat shock protein-90 beta is expressed at the surface of multipotential mesenchymal precursor cells: Generation of a novel monoclonal antibody, STRO-4, with specificity for mesenchymal precursor cells from human and ovine tissues. Stem Cells and Development, 18, 1253-1262.
102. Hamamoto, H., Gorman, J. H., 3rd, Ryan, L. P., et al. (2009). Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: The effect of cell dosage. The Annals of Thoracic Surgery, 87, 794-801.
103. Tondreau, T., Lagneaux, L., Dejeneffe, M., et al. (2004). Isolation of BM mesenchymal stem cells by plastic adhesion or negative selection: Phenotype, proliferation kinetics and differentiation potential. Cytotherapy, 6, 372-379.
104. Lushaj, E. B., Anstadt, E., Haworth, R., et al. (2011). Mesenchymal stromal cells are present in the heart and promote growth of adult stem cells in vitro. Cytotherapy, 13, 400-406.
105. Jiang, Y., Jahagirdar, B., Reinhardt, R., et al. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 418, 41-49.
106. Pelacho, B., Nakamura, Y., Zhang, J., et al. (2007). Multipotent adult progenitor cell transplantation increases vascularity and improves left ventricular function after myocardial infarction. Journal of Tissue Engineering and Regenerative Medicine, 1, 51-59.
107. Spees, J. L., Gregory, C. A., Singh, H., et al. (2004). Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Molecular Therapy, 9, 747-756.
108. Crespo-Diaz, R., Behfar, A., Butler, G. W., et al. (2011). Platelet lysate consisting of a natural repair proteome supports human mesenchymal stem cell proliferation and chromosomal stability. Cell Transplantation, 20, 797-811.
109. Hoogduijn, M. J., Crop, M. J., Peeters, A. M., et al. (2009). Donor-derived mesenchymal stem cells remain present and functional in the transplanted human heart. American Journal of Transplantation, 9, 222-230.
110. Bai, X., Yan, Y., Song, Y. H., et al. (2010). Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction. European Heart Journal, 31, 489-501.
111. Bayes-Genis, A., Soler-Botija, C., Farre, J., et al. (2010). Human progenitor cells derived from cardiac adipose tissue ameliorate myocardial infarction in rodents. Journal of Molecular and Cellular Cardiology, 49, 771-780.
112. Troyer, D. L., & Weiss, M. L. (2008). Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells, 26, 591-599.
113. Iop, L., Chiavegato, A., Callegari, A., et al. (2008). Different cardiovascular potential of adult- and fetal-type mesenchymal stem cells in a rat model of heart cryoinjury. Cell Transplantation, 17, 679-694.
114. Kadivar, M., Khatami, S., Mortazavi, Y., Shokrgozar, M. A., Taghikhani, M., & Soleimani, M. (2006). In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells. Biochemical and Biophysical Research Communications, 340, 639-647.
115. Gaebel, R., Furlani, D., Sorg, H., et al. (2011). Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration. PLoS One, 6(2), e15652.
116. Bieback, K., Kern, S., Kluter, H., & Eichler, H. (2004). Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells, 22, 625-634.
117. Schmidt, D., Mol, A., Breymann, C., et al. (2006). Living autologous heart valves engineered from human prenatally harvested progenitors. Circulation, 114, I125-I131.
118. Lee, S. T., White, A. J., Matsushita, S., et al. (2011). Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. Journal of the American College of Cardiology, 57, 455-465.
119. Gambini, E., Pompilio, G., Biondi, A., et al. (2011). C-kit+cardiac progenitors exhibit mesenchymal markers and preferential cardiovascular commitment. Cardiovascular Research, 89, 362-373.
120. Sethe, S., Scutt, A., & Stolzing, A. (2006). Aging of mesenchymal stem cells. Ageing Research Reviews, 5, 91-116.
121. Tokalov, S. V., Gruner, S., Schindler, S., Wolf, G., Baumann, M., & Abolmaali, N. (2007). Age-related changes in the frequency of mesenchymal stem cells in the bone marrow of rats. Stem Cells and Development, 16, 439-446.
122. Hacia, J. G., Lee, C. C., Jimenez, D. F., et al. (2008). Age-related gene expression profiles of rhesus monkey bone marrow-derived mesenchymal stem cells. Journal of Cellular Biochemistry, 103, 1198-1210.
123. Zhang, H., Fazel, S., Tian, H., et al. (2005). Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapy. American Journal of Physiology - Heart and Circulatory Physiology, 289, H2089-H2096.
124. Khan, M., Mohsin, S., Khan, S. N., & Riazuddin, S. (2011). Repair of senescent myocardium by mesenchymal stem cells is dependent on the age of donor mice. Journal of Cellular and Molecular Medicine, 15, 1515-1527.
125. Khan, M., Kwiatkowski, P., Rivera, B. K., & Kuppusamy, P. (2010). Oxygen and oxygenation in stem-cell therapy for myocardial infarction. Life Sciences, 87, 269-274.
126. Kofoed, H., Sjontoft, E., Siemssen, S. O., & Olesen, H. P. (1985). Bone marrow circulation after osteotomy. Blood flow, pO2, pCO2, and pressure studied in dogs. Acta Orthopaedica Scandinavica, 56, 400-403.
127. Hu, X., Yu, S. P., Fraser, J. L., et al. (2008). Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. The Journal of Thoracic and Cardiovascular Surgery, 135, 799-808.
128. Li, J. H., Zhang, N., & Wang, J. A. (2008). Improved anti-apoptotic and anti-remodeling potency of bone marrow mesenchymal stem cells by anoxic pre-conditioning in diabetic cardiomyopathy. Journal of Endocrinological Investigation, 31, 103-110.
129. Rebelatto, C. K., Aguiar, A. M., Senegaglia, A. C., et al. (2009). Expression of cardiac function genes in adult stem cells is increased by treatment with nitric oxide agents. Biochemical and Biophysical Research Communications, 378, 456-461.
130. Afzal, M. R., Haider, H., Idris, N. M., Jiang, S., Ahmed, R. P., & Ashraf, M. (2010). Pre-conditioning promotes survival and angiomyogenic potential of mesenchymal stem cells in the infarcted heart via NF-kappaB signaling. Antioxidants & Redox Signaling, 12, 693-702.
131. Suzuki, Y., Kim, H. W., Ashraf, M., & Haider, H. (2010). Diazoxide potentiates mesenchymal stem cell survival via NF-kappaB-dependent miR-146a expression by targeting Fas. American Journal of Physiology - Heart and Circulatory Physiology, 299, H1077-H1082.
132. Suzuki, K., Smolenski, R. T., Jayakumar, J., Murtuza, B., Brand, N. J., & Yacoub, M. H. (2000). Heat shock treatment enhances graft cell survival in skeletal myoblast transplantation to the heart. Circulation, 102(19 Suppl 3), III216-III221.
133. Wang, X., Zhao, T., Huang, W., et al. (2009). Hsp20-engineered mesenchymal stem cells are resistant to oxidative stress via enhanced activation of Akt and increased secretion of growth factors. Stem Cells, 27, 3021-3031.
134. Chang, W., Song, B.-W., Lim, S., et al. (2009). Mesenchymal stem cells pretreated with delivered Hph-1-Hsp70 protein are protected from hypoxia-mediated cell death and rescue heart functions from myocardial injury. Stem Cells, 27, 2283-2292.
135. Yang, Y. J., Qian, H. Y., Huang, J., et al. (2009). Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts. Arteriosclerosis, Thrombosis, and Vascular Biology, 29, 2076-2082.
136. Yang, Y., Mou, Y., Hu, S. J., & Fu, M. (2009). Beneficial effect of rosuvastatin on cardiac dysfunction is associated with alterations in calcium-regulatory proteins. European Journal of Heart Failure, 11, 6-13.
137. Lin, Y. C., Leu, S., Sun, C. K., et al. (2010). Early combined treatment with sildenafil and adipose-derived mesenchymal stem cells preserves heart function in rat dilated cardiomyopathy. Journal of Translational Medicine, 8, 88.
138. Haider, H., Lee, Y. J., Jiang, S., Ahmed, R. P., Ryon, M., & Ashraf, M. (2010). Phosphodiesterase inhibition with tadalafil provides longer and sustained protection of stem cells. American Journal of Physiology - Heart and Circulatory Physiology, 299, H1395-H1404.
139. Numasawa, Y., Kimura, T., Miyoshi, S., et al. (2011). Treatment of human mesenchymal stem cells with angiotensin receptor blocker improved efficiency of cardiomyogenic transdifferentiation and improved cardiac function via angiogenesis. Stem Cells, 29, 1405-1414.
140. Wang, Y., Zhang, D., Ashraf, M., et al. (2010). Combining neuropeptide Y and mesenchymal stem cells reverses remodeling after myocardial infarction. American Journal of Physiology - Heart and Circulatory Physiology, 298, H275-H286.
141. Kinnaird, T., Stabile, E., Burnett, M. S., et al. (2004). Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation, 109, 1543-1549.
142. Herrmann, J. L., Wang, Y., Abarbanell, A. M., Weil, B. R., Tan, J., & Meldrum, D. R. (2010). Pre-conditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection. Shock, 33, 24-30.
143. Pasha, Z., Wang, Y., Sheikh, R., Zhang, D., Zhao, T., & Ashraf, M. (2008). Pre-conditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovascular Research, 77, 134-142.
144. Yao, Y., Zhang, F., Wang, L., et al. (2009). Lipopolysaccharide pre-conditioning enhances the efficacy of mesenchymal stem cells transplantation in a rat model of acute myocardial infarction. Journal of Biomedical Science, 16, 74.
145. Matsumoto, R., Omura, T., Yoshiyama, M., et al. (2005). Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 1168-1173.
146. Guo, J., Lin, G., Bao, C., Hu, Z., Chu, H., & Hu, M. (2008). Insulin-like growth factor 1 improves the efficacy of mesenchymal stem cells transplantation in a rat model of myocardial infarction. Journal of Biomedical Science, 15, 89-97.
147. Abbott, J. D., Huang, Y., Liu, D., Hickey, R., Krause, D. S., & Giordano, F. J. (2004). Stromal cell-derived factor-1α plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation, 110, 3300-3305.
148. Kijowski, J., Baj-Krzyworzeka, M., Majka, M., et al. (2001). The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells. Stem Cells, 19, 453-466.
149. Zhuang, Y., Chen, X., Xu, M., Zhang, L. Y., & Xiang, F. (2009). Chemokine stromal cell-derived factor 1/CXCL12 increases homing of mesenchymal stem cells to injured myocardium and neovascularization following myocardial infarction. Chinese Medical Journal, 122, 183-187.
150. Tang, J., Wang, J., Guo, L., et al. (2010). Mesenchymal stem cells modified with stromal cell-derived factor 1 alpha improve cardiac remodeling via paracrine activation of hepatocyte growth factor in a rat model of myocardial infarction. Molecules and Cells, 29, 9-19.
151. Guo, Y. H., He, J. G., Wu, J. L., et al. (2008). Hepatocyte growth factor and granulocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy. Cytotherapy, 10, 857-867.
152. Huang, J., Zhang, Z., Guo, J., et al. (2010). Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium. Circulation Research, 106, 1753-1762.
153. Tang, J., Wang, J., Zheng, F., et al. (2010). Combination of chemokine and angiogenic factor genes and mesenchymal stem cells could enhance angiogenesis and improve cardiac function after acute myocardial infarction in rats. Molecular and Cellular Biochemistry, 339, 107-118.
154. Franke, T. F., Kaplan, D. R., & Cantley, L. C. (1997). PI3K: Downstream AKTion blocks apoptosis. Cell, 88, 435-437.
155. Datta, S. R., Brunet, A., & Greenberg, M. E. (1999). Cellular survival: A play in three Akts. Genes & Development, 13, 2905-2927.
156. Somanath, P. R., Razorenova, O. V., Chen, J., & Byzova, T. V. (2006). Akt1 in endothelial cell and angiogenesis. Cell Cycle, 5, 512-518.
157. Gnecchi, M., He, H., Liang, O. D., et al. (2005). Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nature Medicine, 11, 367-368.
158. Gnecchi, M., He, H., Noiseux, N., et al. (2006). Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. The FASEB Journal, 20, 661-669.
159. Mirotsou, M., Zhang, Z., Deb, A., et al. (2007). Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proceedings of the National Academy of Sciences of the United States of America, 104, 1643-1648.
160. Song, S. W., Chang, W., Song, B. W., et al. (2009). Integrin-linked kinase is required in hypoxic mesenchymal stem cells for strengthening cell adhesion to ischemic myocardium. Stem Cells, 27, 1358-1365.
161. Jiang, Y., Chen, L., Tang, Y., et al. (2010). HO-1 gene overexpression enhances the beneficial effects of superparamagnetic iron oxide labeled bone marrow stromal cells transplantation in swine hearts underwent ischemia/reperfusion: An MRI study. Basic Research in Cardiology, 105, 431-442.
162. Taljaard, M., Ward, M. R., Kutryk, M. J., et al. (2010). Rationale and design of Enhanced Angiogenic Cell Therapy in Acute Myocardial Infarction (ENACT-AMI): The first randomized placebo-controlled trial of enhanced progenitor cell therapy for acute myocardial infarction. American Heart Journal, 159, 354-360.
163. Mias, C., Trouche, E., Seguelas, M. H., et al. (2008). Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney. Stem Cells, 26, 1749-1757.
164. Behfar, A., Zingman, L. V., Hodgson, D. M., et al. (2002). Stem cell differentiation requires a paracrine pathway in the heart. The FASEB Journal, 16, 1558-1566.
165. Behfar, A., Perez-Terzic, C., Faustino, R. S., et al. (2007). Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. The Journal of Experimental Medicine, 204, 405-420.
166. Behfar, A., Yamada, S., Crespo-Diaz, R., et al. (2010). Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. Journal of the American College of Cardiology, 56, 721-734.
167. Bartunek, J., Wijns, W., Dolatabadi, D., et al. (2011). C-cure multicenter trial: Lineage specific bone marrow derived cardiopoietic mesenchymal stem cells for the treatment of ischaemic cardiomyopathy. Journal of the American College of Cardiology, 57, E200. Abstract.
168. Yang, Y.-J., Qian, H.-Y., Huang, J., et al. (2008). Atorvastatin treatment improves survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts. European Heart Journal, 29, 1578-1590.
169. Xu, R., Chen, J., Cong, X., Hu, S., & Chen, X. (2008). Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2. Journal of Cellular Biochemistry, 103, 256-269.
170. Khan, M., Meduru, S., Mohan, I. K., et al. (2009). Hyperbaric oxygenation enhances transplanted cell graft and functional recovery in the infarct heart. Journal of Molecular and Cellular Cardiology, 47, 275-287.
171. Zhang, H., Hou, J. F., Shen, Y., Wang, W., Wei, Y. J., & Hu, S. (2010). Low level laser irradiation precondition to create friendly milieu of infarcted myocardium and enhance early survival of transplanted bone marrow cells. Journal of Cellular and Molecular Medicine, 14, 1975-1987.
172. Briones, E., Lacalle, J. R., Marin, I. (2009) Transmyocardial laser revascularization versus medical therapy for refractory angina. Cochrane Database of Systematic Reviews CD003712
173. Psaltis, P. J., & Worthley, S. G. (2009). Endoventricular electromechanical mapping-the diagnostic and therapeutic utility of the NOGA XP Cardiac Navigation System. Journal of Cardiovascular Translational Research, 2, 48-62.
174. Reyes, G., Allen, K. B., Alvarez, P., et al. (2010). Midterm results after bone marrow laser revascularization for treating refractory angina. BMC Cardiovascular Disorders, 10, 42.
175. Traverse, J. H., Henry, T. D., Ellis, S. G., et al. (2011). Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: The LateTIME randomized trial. Journal of the American Medical Association, 306, 2110-2119.
176. Ly, H. Q., Hoshino, K., Pomerantseva, I., et al. (2009). In vivo myocardial distribution of multipotent progenitor cells following intracoronary delivery in a swine model of myocardial infarction. European Heart Journal, 30, 2861-2868.
177. Hou, D., Youssef, E. A., Brinton, T. J., et al. (2005). Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: Implications for current clinical trials. Circulation, 112, I150-I156.
178. Perin, E. C., Silva, G. V., Assad, J. A., et al. (2008). Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. Journal of Molecular and Cellular Cardiology, 44, 486-495.
179. Mitchell, A. J., Sabondjian, E., Sykes, J., et al. (2010). Comparison of initial cell retention and clearance kinetics after subendocardial or subepicardial injections of endothelial progenitor cells in a canine myocardial infarction model. Journal of Nuclear Medicine, 51, 413-417.
180. Psaltis, P., Zannettino, A., Gronthos, S., & Worthley, S. (2010). Intramyocardial navigation and mapping for stem cell delivery. Journal of Cardiovascular Translational Research, 3, 135-146.
181. Christman, K. L., Vardanian, A. J., Fang, Q., Sievers, R. E., Fok, H. H., & Lee, R. J. (2004). Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. Journal of the American College of Cardiology, 44, 654-660.
182. Leor, J., Amsalem, Y., & Cohen, S. (2005). Cells, scaffolds, and molecules for myocardial tissue engineering. Pharmacology and Therapeutics, 105, 151-163.
183. Kofidis, T., Lebl, D. R., Martinez, E. C., Hoyt, G., Tanaka, M., & Robbins, R. C. (2005). Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Circulation, 112(9 Suppl), I173-I177.
184. Terrovitis, J., Lautamaki, R., Bonios, M., et al. (2009). Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. Journal of the American College of Cardiology, 54, 1619-1626.
185. Davis, M. E., Motion, J. P. M., Narmoneva, D. A., et al. (2005). Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation, 111, 442-450.
186. Segers, V. F., Tokunou, T., Higgins, L. J., MacGillivray, C., Gannon, J., & Lee, R. T. (2007). Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation, 116, 1683-1692.
187. Barnett, B. P., Ruiz-Cabello, J., Hota, P., et al. (2011). Fluorocapsules for improved function, immunoprotection, and visualization of cellular therapeutics with MR, US, and CT imaging. Radiology, 258, 182-191.
188. Melero-Martin, J. M., De Obaldia, M. E., Kang, S. Y., et al. (2008). Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circulation Research, 103, 194-202.